Home
Live Updates
Agios Stock Poised To Break Out On $905 Million Brain Cancer Deal : comparemela.com
Agios Stock Poised To Break Out On $905 Million Brain Cancer Deal
Agios agreed Tuesday to sell its 15% royalty in a brain cancer drug for $905 million upfront. Agios stock broke out at the open.
Related Keywords
Brian Goff ,
Agios Pharmaceuticals ,
Drug Administration ,
Royalty Pharma ,
Chief Executive Brian Goff ,
comparemela.com © 2020. All Rights Reserved.